Age-related changes of serum tartrate-resistant acid phosphatase 5b and the relationship with bone mineral density in Chinese women

Acta Pharmacologica Sinica

Volumn 29, Issue 12, 2008, Pages 1493-1498

  Qin, Yue Juan ^a,b   Zhang, Zhen Lin ^a   Zhang, Hao ^a   Hu, Wei Wei ^a   Liu, Yu Juan ^a   Hu, Yun Qiu ^a   Li, Miao ^a   Gu, Jie Mei ^a   He, Jin Wei ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Bone mineral density; Bone turnover; TRACP5b

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; TARTRATE RESISTANT ACID PHOSPHATASE 5B; UNCLASSIFIED DRUG; ACID PHOSPHATASE; BIOLOGICAL MARKER; ISOENZYME; TARTRATE-RESISTANT ACID PHOSPHATASE;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MASS; CHINESE; CLINICAL EVALUATION; COMPARATIVE STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR; GROUPS BY AGE; HUMAN; HUMAN EXPERIMENT; IMMUNOASSAY; LUMBAR SPINE; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; POSTMENOPAUSE; PREMENOPAUSE; REFERENCE VALUE; AGING; BLOOD; CHINA; METABOLIC BONE DISEASE; METABOLISM; MIDDLE AGED; PHOTON ABSORPTIOMETRY; POSTMENOPAUSE OSTEOPOROSIS;

ABSORPTIOMETRY, PHOTON; ACID PHOSPHATASE; ADULT; AGED; AGING; BIOLOGICAL MARKERS; BONE DENSITY; BONE DISEASES, METABOLIC; BONE RESORPTION; CHINA; FEMALE; HUMANS; ISOENZYMES; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; YOUNG ADULT;

EID: 64549116825     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2008.00890.x     Document Type: Article

References (25)

1. Looker AC, Bauer DC, Chesnut CH 3rd, Gundberg CM, Hochberg MC, Klee G, et al. Clinical use of biochemical markers of bone remodeling: current status and future directions. Osteooros Int 2000; 11: 467-80.
2. De Leo V, Ditto A, la Marca A, Lanzetta D, Massafra C, Morgante G et al. Bone mineral density and biochemical markers of bone turnover in peri- and postmenopausal women. Calcif Tisue Int 2000; 66: 263-7
3. Halleen JM, Alatalo SL, Suominen H, Cheng S, Janckila AJ, Vää- nänen HK. Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption. J Bone Miner Res 2000; 15: 1337-45.
4. Ohashi T, Igarashi Y, Mochizuki Y, Miura T, Inaba N, Katayama K, et al. Development of a novel fragments absorbed immunocapture enzyme assay system for tartrate-resistant acid phosphatase 5b. Clin Chim Acta 2007; 376: 205-12.
5. Halleen JM, Hentunen TA, Karp M, Käkönen SM, Pettersson K, Väänänen HK. Characterization of serum tartrate-resistant acid phosphatase and development of a direct two-site immunoassay. J Bone Miner Res 1998; 13: 683-7.
6. Miyazaki S, Igarashi M, Nagata A, Tominaga Y, Onodera K, Komoda T. Development of immunoassays for type-5 tartrate-resistant aid phosphatase in human serum. Clin Chim Acta 2003; 329: 109-15.
7. Väänänen HK, Zhao H, Mulari M, Halleen JM. The cell biology of osteoclast function. J Cell Sci 2000; 113: 377-81.
8. Rosenbrock H, Seifert-Klauss V, Kaspar S, Busch R, Luppa PB. Changes of biochemical bone markers during the menopausal transition. Clin Chem Lab Med 2002; 40: 143-51.
9. Halleen JM, Ylipahkala H, Alatalo SL, Janckila AJ, Heikkinen JE, Suominen H, et al. Serum tartrate-resistant acid phosphatase 5b, but not 5a, correlates with other markers of bone turnover and bone mineral density. Calcif Tissue Int 2002; 71: 20-5
10. Halleen HM. Tartrate-resistant acid phosphatase 5b is a specifc and sensitive marker of bone resorption. Anticancer Res 2003; 23: 1027-9
11. Nishizawa Y, Nakamura T, Ohta H, Kushida K, Gorai I, Shiraki M, et al. Guideline for the use of biochemical markers of bone turnover in osteoporosis. J Bone Miner Metab 2005; 23: 97-104.
12. Shan PF, Wu XP, Zhang H, Luo XH, Cao XZ, Xie H, et al. Agerelated changes of serum bone alkaline phosphatase and cross-linked C-telopeptides of type I collagen and relationship with bone mineral density in Chinese women. Clin Chim Acta 2006; 366: 233-8.
13. Yan L, Prentice A, Zhou B, Zhang H, Wang X, Stirling DM, et al. Age- and gender-related differences in bone mineral status and biochemical markers of bone metabolism in Northern Chinese men and women. Bone 2002; 30: 412-5.
14. Halleen JM, Alatalo SL, Janckila AJ, Woitge HW, Seibel MJ, Väänänen HK. Serum tartrate-resistant acid phosphatase 5b is a specifc and sensitive marker of bone resorption. Clin Chem 2001; 47: 597-600.
15. Miyazaki S, Igarashi M, Nagata A, Tominaga Y, Onodera K, Komoda T. Development of immunoassays for type-5 tartrate-resistant acid phosphatase in human serum. Clin Chim Acta 2003; 329: 109-15.
16. Janckila AJ, Takahashi K, Sun SZ, Yam LT. Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity. Clin Chem 2001; 47: 74-80
17. Chao TY, Yu JC, Ku CH, Chen MM, Lee SH, Janckila AJ, et al. Tartrate-resistant acid phosphatase 5b is a useful serum marker for extensive bone metastasis in breast cancer patients. Clin Cancer Res 2005; 11: 544-50.
18. Huang QR, Zhou Q, Lu JH, Hu YQ, Liu YJ, Qin YJ. Bone mineral density and age-related bone loss in 2111 healthy women in Shanghai. Chin J Osteoporos 2002; 8: 191-4.
19. Zhang ZL, He JW, Qin YJ, Hu YQ, Li M, Liu YJ, et al. Association between the SNPs and haplotypes in the PPARGC1 and adiponectin genes and bone mineral density in Chinese women and men. Acta Pharmacol Sin 2007; 28: 287-95.
20. Garnero P, Shih WJ, Gineyts E, Karpf DB, Delmas PD. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab 1994; 79: 1693-700.
21. Garnero P, Grimaux M, Demiaux B, Preaudat C, Seguin P, Delmas PD. Measurement of serum osteocalcin with a human-specifc twosite immunoradiometric assay. J Bone Miner Res 1992; 7: 1389-98.
22. Nishizawa Y, Inaba M, Ishii M, Yamashita H, Miki T, Goto H, et al. Reference intervals of serum tartrate-resistant acid phosphatase type 5b activity measured with a novel assay in Japanese subjects. J Bone Miner Metab 2008; 26: 265-70.
23. Gerdhem P, Ivaska KK, Alatalo SL, Halleen JM, Hellman J, Isaksson A, et al. Biochemical marker of bone metabolism and prediction of fracture in elderly women. J Bone Miner Res 2004; 19: 386-93.
24. Välimäki MJ, Tähtelä R. Serum tartrate-resistant acid phosphatase 5b or amino-terminal propeptide of type I procollagen for monitoring bisphosphonate therapy in postmenopausal osteoporosis? Clin Chem 2005; 51: 2382-5.
25. Rogers A, Hannon RA, Eastell R. Biochemical markers as predictors of rates of bone loss after menopause. J Bone Miner Res 2000; 15: 1398-404.